Homeland Nickel Inc. (TSXV:SHL)

Sage Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	16	11	11	14	26	6
Market Cap Growth	-49.91%	2.99%	-25.00%	-45.22%	365.16%	47.79%
Enterprise Value	11	-0	0	-4	4	6
Last Close Price	0.07	0.05	0.06	0.08	0.12	0.03
PE Ratio	-	34.71	-	-	1.21	0.66
PS Ratio	-	-	178.34	109.72	-	-
PB Ratio	1.55	0.79	1.04	0.89	0.82	0.49
P/TBV Ratio	1.56	0.85	1.04	0.89	0.82	0.49
EV/Sales Ratio	-	-	5.19	-	-	-
EV/FCF Ratio	-8.54	-	-	-	-	-
Debt / Equity Ratio	-	-	0.01	0.00	0.00	0.00
Asset Turnover	-	-	0.00	0.01	-	-
Quick Ratio	9.48	31.05	59.22	22.21	29.13	12.33
Current Ratio	9.60	31.26	59.43	22.26	30.25	13.84
Return on Equity (ROE)	-41.39%	2.61%	-43.66%	-44.01%	99.25%	134.25%
Return on Assets (ROA)	-10.95%	-10.48%	-4.42%	-6.69%	-3.17%	-3.82%
Return on Capital (ROIC)	-11.23%	-10.63%	-4.53%	-7.02%	-3.33%	-4.06%
Earnings Yield	-30.74%	2.88%	-53.77%	-73.94%	82.35%	152.24%
FCF Yield	-8.56%	-12.79%	-4.62%	-21.84%	-5.29%	-17.49%
Buyback Yield / Dilution	-18.57%	-6.44%	-3.28%	-28.52%	-38.46%	-9.52%

Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.